1ST Biotherapeutics Competitors and Similar CompaniesClear all

1ST Biotherapeutics's competitors and similar companies include Cipla, Alembic Pharmaceuticals, UCB and Genentech.

	1ST Biotherapeutics 1ST Biotherapeutics is a company that specializes in the discovery and development of therapeutic candidates.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 2016	Founding Date 1935	Founding Date 2010	Founding Date 1928	Founding Date 1976
Type	Type Private	Type Public	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Do, KR HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 24	Employees 27,764	Employees 14,858	Employees 9,052	Employees 18,077
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods ₹19.8b (FY, 2026)	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit ₹54.1b (FY, 2026)	Gross profit €7.2b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income ₹6.7b (FY, 2026)	Net income €1.6b (FY, 2025)	Net income N/A
Operating ⚠
Products	Products N/A	Products 1.5 k (FY, 2024)	Products 145 (FY, 2024)	Products N/A	Products N/A